참고문헌
- Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 2006;18(3):228-33. https://doi.org/10.1097/01.cco.0000219250.15041.f8
- Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 2002;24(2):165-80. https://doi.org/10.1002/hed.10004
- Sandler HC. Cytological screening for early mouth cancer. Cancer 1962;15:1119 -24. https://doi.org/10.1002/1097-0142(196211/12)15:6<1119::AID-CNCR2820150605>3.0.CO;2-A
- Messadi DV, Wilder-Smith P, Wolinsky L. Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc 2009;37(11):789-98.
- Farah CS, McCullough MJ. A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol 2007;43(8):820-4. https://doi.org/10.1016/j.oraloncology.2006.10.005
- Ram S, Siar CH. Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 2005 ;34(5):521-7. https://doi.org/10.1016/j.ijom.2004.10.008
- Zhang L, Williams M, Poh CF, et al. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome. Cancer Res 2005;65(17):8017-21.
- Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14(19):6246-52. https://doi.org/10.1158/1078-0432.CCR-07-5037
- Franzmann EJ, Reategui EP, Pedroso F, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007;16(7):1348-55. https://doi.org/10.1158/1055-9965.EPI-06-0011
- Nagler R, Bahar G, Shpitzer T, Feinmesser R. Concomitant analysis of salivary tumor markers--a new diagnostic tool for oral cancer. Clin Cancer Res 2006; 12(13):3979-84. https://doi.org/10.1158/1078-0432.CCR-05-2412
- Tavassoli M, Brunel N, Maher R, Johnson NW, Soussi T. p53 antibodies in the saliva of patients with squamous cell carcinoma of the oral cavity. Int J Cancer 1998;78(3):390-1. https://doi.org/10.1002/(SICI)1097-0215(19981029)78:3<390::AID-IJC23>3.0.CO;2-9
- Wei J, Xie G, Zhou Z, et al. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2010.
- Park NJ, Zhou H, Elashoff D, et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res 2009;15(17):5473-7. https://doi.org/10.1158/1078-0432.CCR-09-0736